These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
67 related items for PubMed ID: 6495257
21. Phase I trial of cytarabine and hydroxyurea. Pfeifle CE, Howell SB. Cancer Treat Rep; 1983 Dec; 67(12):1127-9. PubMed ID: 6652629 [Abstract] [Full Text] [Related]
22. [Treatment of refractory hematologic malignancies by combination of cytarabine ocfosfate and etoposide]. Kiyama Y, Suzuki G, Masauzi N, Ohizumi H, Kobayashi N, Ogasawara M, Naohara T, Saito M, Higa T, Kasai M. Gan To Kagaku Ryoho; 1996 Oct; 23(12):1717-20. PubMed ID: 8886052 [Abstract] [Full Text] [Related]
23. [Acute leukemia: which of two types of cell death (necrosis or apoptosis) may be responsible for patients' death during intensive chemotherapy?]. Petukhov VI, Pavlov BN. Ter Arkh; 2002 Oct; 74(12):100-4. PubMed ID: 12577856 [No Abstract] [Full Text] [Related]
24. [Mitoxantrone-aracytine with or without quinine in the treatment of refractory or relapsed acute leukemia]. Solary E, Witz F, Moreau P, Quiquandon I, Genne P, Flesch M, Saddoun A, Maloisel F, Pignon B, Abgrall JF. Nouv Rev Fr Hematol (1978); 1994 Jul; 36 Suppl 2():S141-3. PubMed ID: 7971263 [No Abstract] [Full Text] [Related]
25. [Coagulation system in patients with blood malignancies treated with estrogens in the course of cytostatic therapy]. Ignashina EV, Vasil'ev SA, Pivnik AV, Shilin DE, Margolin OV, Kozhurin SV. Ter Arkh; 1998 Jul; 70(10):46-8. PubMed ID: 9864804 [Abstract] [Full Text] [Related]
26. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience]. Rolovitsh Z, Cholovitsh M, Elezovitsh I, Vidovitsh A, Radoshevitsh-Radojkovitsh N, Boshkovitsh D, Novak A, Basara N. Srp Arh Celok Lek; 1995 Jul; 123(11-12):279-85. PubMed ID: 16296239 [Abstract] [Full Text] [Related]
27. [Treatment strategies for childhood acute leukemia and their effectiveness: message to internists from a pediatrician]. Hujimoto T. Rinsho Ketsueki; 1999 Apr; 40(4):255-61. PubMed ID: 10355130 [No Abstract] [Full Text] [Related]
28. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study. Brusamolino E, Anselmo AP, Klersy C, Santoro M, Orlandi E, Pagnucco G, Lunghi F, Maurizi-Enrici R, Baroni CD, Lazzarino M, Mandelli F, Bernasconi C. Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578 [Abstract] [Full Text] [Related]
29. Acute leukemia during pregnancy: a report on 37 patients and a review of the literature. Chelghoum Y, Vey N, Raffoux E, Huguet F, Pigneux A, Witz B, Pautas C, de Botton S, Guyotat D, Lioure B, Fegueux N, Garban F, Saad H, Thomas X. Cancer; 2005 Jul 01; 104(1):110-7. PubMed ID: 15912518 [Abstract] [Full Text] [Related]
30. Acute myelogenous leukemia following radiation therapy and chemotherapy for osteogenic sarcoma. Jacobs AD, Gale RP. Cancer Treat Rep; 1984 Jun 01; 68(6):909-11. PubMed ID: 6587934 [Abstract] [Full Text] [Related]
32. Recombinant activated factor VII for severe uterine bleeding after chemotherapy in a woman with acute myeloid leukemia. Erikci AA, Ozturk A, Sayan O. Blood Coagul Fibrinolysis; 2006 Jun 01; 17(4):323-4. PubMed ID: 16651877 [Abstract] [Full Text] [Related]
33. [Therapeutic effects of peripheral blood stem cell transplantation following combination chemotherapy using ranimustine, cytarabine, etoposide and cyclophosphamide for patients with hematological malignancies]. Yamane T, Ohta T, Kou KR, Hashimoto S, Takekawa K, Hirai N, Tanaka K, Hasuike T, Hirai M, Ohta K. Gan To Kagaku Ryoho; 1994 May 01; 21(6):903-6. PubMed ID: 7910450 [No Abstract] [Full Text] [Related]
36. Mitoxantrone and cytosine arabinoside (ARA-C) in adult acute leukemia: an interim report. Kansu E, Koc Y, Kars A, Alakavuklar M, Tekuzman G, Firat D. J Chemother; 1989 Jul 01; 1(4 Suppl):1268-70. PubMed ID: 16312861 [No Abstract] [Full Text] [Related]
37. [Complications associated with short-term intensive consolidation chemotherapy for adults with acute myelogenous leukemia]. Nagata K, Abe Y, Hatanaka T, Ito T, Saito M, Ono Y, Kamiya O, Ohara K. Gan To Kagaku Ryoho; 1993 Sep 01; 20(12):1869-72. PubMed ID: 8379681 [No Abstract] [Full Text] [Related]
38. [Acute leukemia]. Sánchez-Cortés E, González-Llaven J. Rev Invest Clin; 1997 May 01; 49 Suppl 1():103-7. PubMed ID: 9380982 [No Abstract] [Full Text] [Related]
39. Pilot study of 5-azacytidine (5-AZA) and carboplatin (CBDCA) in patients with relapsed/refractory leukemia. Kritz AD, Raptis G, Menendez-Botet C, Maslak P, Jakubowski A. Am J Hematol; 1996 Feb 01; 51(2):117-21. PubMed ID: 8579051 [Abstract] [Full Text] [Related]